IAIM
MRKR icon

International Assets Investment Management’s Marker Therapeutics MRKR Stock Holding History

International Assets Investment Management’s Portfolio MRKR Stock Details MRKR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.9K Hold
2,000
– – ﹤0.01% 2076
2026
Q1 		$2.62K Hold
2,000
– – ﹤0.01% 1947
2025
Q4 		$2.98K Buy
+2,000
New +$2.27K ﹤0.01% 1900
2024
Q3 		– Sell
-2,000
Closed -$10.9K – 2343
2024
Q2 		$10.9K Buy
+2,000
New +$8.5K ﹤0.01% 1646

Other funds holding MRKR

LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
CIA
Concurrent Investment Advisors Tampa, Florida $11.8B AUM 31.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
ATPW
Ashton Thomas Private Wealth Scottsdale, Arizona $4.79B AUM 27.94% 1-Year Est. Return
Fifth Third Bancorp
Fifth Third Bancorp Cincinnati, Ohio $61.7B AUM 33.76% 1-Year Est. Return
S
SignatureFD Atlanta, Georgia $7.49B AUM 24.82% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.26% 1-Year Est. Return
HNB
Hilltop National Bank Casper, Wyoming $468M AUM 36.09% 1-Year Est. Return
CIAM
Caitong International Asset Management Hong Kong $729M AUM 1,176.98% 1-Year Est. Return

International Assets Investment Management's MRKR Position: Q2 2026 in Review

International Assets Investment Management held its Marker Therapeutics (MRKR) position steady in Q2 2026 at 2,000 shares worth $2.9K. The position accounts for ﹤0.01% of the portfolio, ranked #2076.

International Assets Investment Management first reported a position in MRKR in Q2 2024 and has held it in 4 quarters since. The position peaked at $10.9K in Q2 2024. 10 funds tracked by Wall St. Rank hold MRKR as of Q2 2026.

  • International Assets Investment Management held 2,000 shares of Marker Therapeutics worth $2.9K as of Q2 2026.
  • International Assets Investment Management left its Marker Therapeutics share count unchanged in Q2 2026.
  • Marker Therapeutics made up ﹤0.01% of International Assets Investment Management's portfolio in Q2 2026, its #2076 holding.
  • International Assets Investment Management first reported a position in Marker Therapeutics in Q2 2024 and has held it in 4 quarters since.
  • International Assets Investment Management's Marker Therapeutics position peaked at $10.9K in Q2 2024.
  • 10 funds tracked by Wall St. Rank held Marker Therapeutics as of Q2 2026.

Based on International Assets Investment Management's 13F filing for Q2 2026, filed 22 Jul 2026.